The theory behind m r and a vaccines had been around for decades, but it is only recently that companies like madurna figured out how to make it work in practice. Arna vaccines are really revolutionary because they outsource part of the vaccine production to your own cells. Newbar opens stephon's eyes to m rna's potential to re configure the risk reward calculus of drug development.
If you're launching a moonshot, success depends on how you manage the trajectory of risk. When Stéphane Bancel became Moderna's first CEO, the biotech start-up was chasing a way-out idea many experts thought was impossible. Stéphane built a culture of calculated risk-taking to create a platform for extraordinary leaps — one that enabled life-saving mRNA vaccines when Covid-19 struck.
Read a transcript of this episode: https://mastersofscale.com
Subscribe to the Masters of Scale weekly newsletter: https://mastersofscale.com/subscribe
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.